Literature DB >> 2840993

Inhibition by nedocromil sodium of early and late phase bronchoconstriction and airway cellular infiltration provoked by ovalbumin inhalation in conscious sensitized guinea-pigs.

P A Hutson1, S T Holgate, M K Church.   

Abstract

Bronchial challenge of ovalbumin-sensitized conscious guinea-pigs induced a triphasic reduction in specific airways conductance (sGaw) with maximal reductions being observed at 2, 17 and 72 h accompanied by infiltration of the airways with neutrophils at 17 h and eosinophils at 17 and 72 h. Nedocromil sodium (10 mg ml-1) inhaled before challenge blocked the 2 and 17 h sGaw response and the neutrophil influx. When inhaled 6 h after challenge, nedocromil inhibited the 17 h sGaw response but not neutrophil influx, suggesting that these are unrelated. The sGaw response and eosinophil accumulation at 72 h was also inhibited by nedocromil given at this time. Our findings correlate with the clinical effects of nedocromil, suggesting the guinea-pig model may be useful for investigating the mechanism of action of anti-asthmatic drugs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840993      PMCID: PMC1853941          DOI: 10.1111/j.1476-5381.1988.tb11493.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation.

Authors:  W J Metzger; H B Richerson; K Worden; M Monick; G W Hunninghake
Journal:  Chest       Date:  1986-04       Impact factor: 9.410

2.  Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions.

Authors:  S R Durham; A B Kay
Journal:  Clin Allergy       Date:  1985-09

3.  The clinical development of a new agent for the treatment of airway inflammation, nedocromil sodium (Tilade).

Authors:  R M Auty
Journal:  Eur J Respir Dis Suppl       Date:  1986

4.  Preliminary report on the effect of nedocromil sodium on antigen-induced early and late reactions in allergic sheep.

Authors:  W M Abraham; J S Stevenson; M S Sielczak
Journal:  Eur J Respir Dis Suppl       Date:  1986

Review 5.  Clinical evaluation of nedocromil sodium in asthma.

Authors:  S T Holgate
Journal:  Eur J Respir Dis Suppl       Date:  1986
  5 in total
  9 in total

1.  Inhibition of platelet-activating factor- and zymosan-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate.

Authors:  P L Bruijnzeel; R A Warringa; P T Kok
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

2.  Effect of nedocromil sodium on early and late phase responses to allergen challenge in the guinea-pig.

Authors:  M K Church; P A Hutson; S T Holgate
Journal:  Drugs       Date:  1989       Impact factor: 9.546

Review 3.  Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

4.  Inflammatory mediators and cellular infiltration of the lungs in a guinea pig model of the late asthmatic reaction.

Authors:  A F Walls; Y K Rhee; D J Gould; C Walters; C Robinson; M K Church; S T Holgate
Journal:  Lung       Date:  1991       Impact factor: 2.584

5.  Effects of bradykinin receptor antagonists on antigen-induced respiratory distress, airway hyperresponsiveness and eosinophilia in guinea-pigs.

Authors:  S G Farmer; D E Wilkins; S A Meeker; E A Seeds; C P Page
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

6.  Nedocromil sodium inhibits airway hyperresponsiveness and eosinophilic infiltration induced by repeated antigen challenge in guinea-pigs.

Authors:  R R Schellenberg; K Ishida; R J Thomson
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

7.  Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection.

Authors:  S Desquand; J Lefort; C Dumarey; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

8.  Prevention of non-specific airway hyperreactivity after allergen challenge in guinea-pigs by the PAF receptor antagonist SDZ 64-412.

Authors:  A M Havill; R G Van Valen; D A Handley
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

9.  Nedocromil sodium prevents in vivo generation of the eosinophilotactic substance induced by PAF but fails to antagonize its effects.

Authors:  P M e Silva; M A Martins; H C Castro-Faria-Neto; P T Bozza; A L Pires; R S Cordeiro; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.